Back
Recursion Pharmaceuticals Vs. BNP Paribas Industry Stock Comparison
Sell
36
RXRX
Recursion Pharmaceuticals
Last Price:
$5.57
Seasonality Move:
-20.8%
Buy
65
BNPQF
BNP Paribas
Last Price:
$95.00
Seasonality Move:
0.91%
Sell
36
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
-
The current Recursion Pharmaceuticals [RXRX] share price is $5.39. The Score for RXRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
BNP Paribas (BNPQF)
is a Buy
Is BNP Paribas a Buy, Sell or Hold?
-
The current BNP Paribas [BNPQF] share price is $95.00. The Score for BNPQF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
BNPQF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $5.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight buying pressure.
BNPQF Stock Price Chart
What is BNP Paribas's stock price today?
-
The BNP Paribas share price today is $95.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNPQF is experiencing slight buying pressure.
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.46 | Buy |
Relative Strength Index (14 RSI): | 54.36 | Buy |
Chaikin Money Flow: | 1391583 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.98 - 5.42) | Buy |
Bollinger Bands (100): | (4.3 - 6.74) | Sell |
BNPQF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 68.06 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (87.77 - 92.43) | Buy |
Bollinger Bands (100): | (79.18 - 90.4) | Buy |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.35 | Buy |
20-day SMA: | 5.2 | Buy |
50-day SMA: | 4.84 | Buy |
200-day SMA: | 6.25 | Sell |
8-day EMA: | 4.44 | Buy |
20-day EMA: | 2.71 | Buy |
50-day EMA: | 1.32 | Buy |
200-day EMA: | 0.37 | Buy |
BNPQF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.45 | Buy |
20-day SMA: | 90.1 | Buy |
50-day SMA: | 88.9 | Buy |
200-day SMA: | 75.23 | Buy |
8-day EMA: | 92.7 | Buy |
20-day EMA: | 90.98 | Buy |
50-day EMA: | 88.4 | Buy |
200-day EMA: | 78.72 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.
BNP Paribas Earnings Growth & BNPQF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Recursion Pharmaceuticals Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BNP Paribas Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |